ADVFN US – Market Content Editor
-
Johnson & Johnson’s 2026 outlook beats forecasts despite expected pricing headwind
Johnson & Johnson (NYSE:JNJ) on Wednesday issued sales and profit guidance for the current year that came in ahead of Wall Street expectations, even as the healthcare group prepares for a financial impact of “hundreds of millions” of dollars tied to a recent U.S. drug pricing agreement. Earlier this month, J&J agreed to cut prices…
-
Truist slides nearly 5% after Q4 earnings and revenue miss
Truist Financial Corp. (NYSE:TFC) posted fourth-quarter results on Wednesday that came in below Wall Street expectations, overshadowing continued growth in loans and net interest income. Shares of the Charlotte-based lender fell 4.84% in premarket trading following the release. Truist reported net income available to common shareholders of $1.29 billion, equal to $1.00 per diluted share,…
-
Citizens Financial Group tops Q4 forecasts as profit jumps year on year
Citizens Financial Group (NYSE:CFG) reported stronger-than-expected results for the fourth quarter on Wednesday, with net income climbing 32% from a year earlier to $528 million. Earnings per share came in at $1.13, ahead of the $1.10 consensus forecast. Despite the earnings beat, the bank’s shares slipped 0.77% in after-hours trading following the release. The Providence,…
-
United Airlines gains as strong premium demand lifts quarterly results
Shares of United Airlines (NASDAQ:UAL) rose more than 3% in U.S. premarket trading on Wednesday after the carrier reported fourth-quarter profit and revenue that topped market expectations, helped by resilient demand from higher-yielding premium travelers. For the quarter ended December, United delivered diluted earnings per share of $3.19, ahead of analysts’ consensus forecast of $2.96.…
-
Ford to recall more than 116,000 U.S. vehicles over potential fire hazard
Ford Motor Company (NYSE:F) is recalling 116,672 vehicles across the United States after regulators identified an electrical fault that could raise the risk of a fire, according to a statement released Wednesday by the National Highway Traffic Safety Administration (NHTSA). The recall follows findings that a possible electrical short circuit in the affected models could…
-
Netflix drops premarket after issuing cautious outlook amid Warner Bros. bid
Shares of Netflix (NASDAQ:NFLX) slid more than 5% in U.S. premarket trading on Wednesday after the streaming group released softer-than-expected forward guidance while pursuing a large acquisition of Warner Bros. Discovery (NASDAQ:WBD). For the quarter ended December 31, Netflix reported earnings of $0.56 per diluted share on revenue of $12.05 billion, narrowly topping analysts’ forecasts…
-
Kraft Heinz slips premarket after filing signals possible Berkshire exit
Shares of Kraft Heinz (NASDAQ:KHC) fell about 3.6% in premarket trading on Wednesday after a regulatory filing indicated that Berkshire Hathaway (NYSE:BRK.B) may look to sell its 27.5% stake in the food group. The disclosure showed that the conglomerate led by Warren Buffett is evaluating a potential divestment of its sizeable holding in Kraft Heinz,…
-
Musk warns Tesla Cybercab and Optimus rollout will start ‘agonizingly slow’
Tesla Inc (NASDAQ:TSLA) chief executive Elon Musk said on Tuesday that the initial manufacturing phase for the company’s upcoming Cybercab robotaxi and Optimus humanoid robot will progress at a very slow pace before accelerating significantly over time. Replying to a post on social media discussing Cybercab production, Musk cautioned that “for Cybercab and Optimus, almost…
-
PDD jumps in U.S. premarket as China fine comes in lighter than expected
Shares of PDD (NASDAQ:PDD) climbed sharply in U.S. premarket trading on Wednesday after news that the company had been hit with a relatively small regulatory penalty in China. According to a report by Chinese state news agency Xinhua, PDD was fined 100,000 yuan ($14,359) by a district-level taxation bureau in Shanghai for failing to submit…
-
Corvus Pharmaceuticals slides premarket after unveiling $150m equity raise
Shares of Corvus Pharmaceuticals (NASDAQ:CRVS) fell sharply in premarket trading on Wednesday, down about 9.9%, after the company disclosed plans for a $150 million stock offering. The biopharmaceutical group did not release further information on the structure or pricing of the proposed issuance in its initial announcement. Equity offerings are commonly viewed as dilutive for…